Powered by

Genesis Therapeutics, Unifying AI and Biotech to Accelerate and Optimize Drug Discovery/Development, Raises $4.1M in Seed Funding Led by Andreessen Horowitz; Company Launched with Breakthrough AI Research from Stanford's Pande Lab; Leonard Bell, M.D., Cha

Nov 21, 2019 - Business Wire

Genesis Therapeutics, a biotech company harnessing breakthrough AI-technology to optimize drug discovery and development, today announced that it has raised $4.1 million in seed funding led by Andreessen Horowitz (a16z) with Felicis Ventures as a major investor. Genesis aims to discover and develop innovative small molecule drug candidates for the treatment of patients with severe and debilitating disorders. The company also expects to strategically partner with pharmaceutical companies to bring...